Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population

Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population

COVID-19 is a pandemic caused by SARS-CoV-2. In Chile, half a million people have been infected and more than 16,000 have died from COVID-19. As part of the clinical trial NCT04384588, we quantified IgG against S1-RBD of SARS-CoV-2 (anti-RBD) in recovered people in Santiago and evaluated their suita...

Full description

Saved in:
Bibliographic Details
Main Authors: R. González-Stegmaier, K. Cereceda, J. L. Briones, C. Beltran-Pávez, A. Oyarzún-Arrau, S. Riquelme-Barrios, C. Selman, F. Yarad, M. Mahave, C. Caglevic, R. Morales, A. Aguirre, F. Valiente-Echeverría, R. Soto-Rifo, H. Marsiglia, R. Gazitua, F. Villarroel-Espindola
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2021/6680337
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.1155/2021/6680337

Similar Items